We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
The Angel® Catheter Clinical Trial
Updated: 1/7/2016
The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
Updated: 1/7/2016
Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial: a Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
Status: Enrolling
Updated: 1/7/2016
A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
Updated: 1/7/2016
Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial: a Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
CRT Pilot Study for Children With Heart Failure
Updated: 1/7/2016
Cardiac Resynchronization Therapy for Children and Adolescents With Advanced Hearth Failure: A Pilot Study
Status: Enrolling
Updated: 1/7/2016
CRT Pilot Study for Children With Heart Failure
Updated: 1/7/2016
Cardiac Resynchronization Therapy for Children and Adolescents With Advanced Hearth Failure: A Pilot Study
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Updated: 1/7/2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Exploring Behavioral Interventions to Improve Heart Failure
Updated: 1/7/2016
Exploring Tai Chi as a Behavioral Intervention for Heart Failure Patients
Status: Enrolling
Updated: 1/7/2016
Exploring Behavioral Interventions to Improve Heart Failure
Updated: 1/7/2016
Exploring Tai Chi as a Behavioral Intervention for Heart Failure Patients
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Reconstruction of 12-Lead Electrogram From Intracardiac Signals From Defibrillators During or After Implantation
Updated: 1/8/2016
Reconstruction of 12-Lead Electrogram From Intracardiac Signals From Defibrillators During or After Implantation
Status: Enrolling
Updated: 1/8/2016
Reconstruction of 12-Lead Electrogram From Intracardiac Signals From Defibrillators During or After Implantation
Updated: 1/8/2016
Reconstruction of 12-Lead Electrogram From Intracardiac Signals From Defibrillators During or After Implantation
Status: Enrolling
Updated: 1/8/2016
Click here to add this to my saved trials
Reconstruction of 12-Lead Electrogram From Intracardiac Signals From Defibrillators During or After Implantation
Updated: 1/8/2016
Reconstruction of 12-Lead Electrogram From Intracardiac Signals From Defibrillators During or After Implantation
Status: Enrolling
Updated: 1/8/2016
Reconstruction of 12-Lead Electrogram From Intracardiac Signals From Defibrillators During or After Implantation
Updated: 1/8/2016
Reconstruction of 12-Lead Electrogram From Intracardiac Signals From Defibrillators During or After Implantation
Status: Enrolling
Updated: 1/8/2016
Click here to add this to my saved trials
Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation
Updated: 1/8/2016
Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation
Status: Enrolling
Updated: 1/8/2016
Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation
Updated: 1/8/2016
Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation
Status: Enrolling
Updated: 1/8/2016
Click here to add this to my saved trials
Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery
Updated: 1/8/2016
A Prospective, Non-randomized, Two Arm, Multi-center Clinical Trial to Evaluate the Safety and Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System and the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.
Status: Enrolling
Updated: 1/8/2016
Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery
Updated: 1/8/2016
A Prospective, Non-randomized, Two Arm, Multi-center Clinical Trial to Evaluate the Safety and Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System and the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.
Status: Enrolling
Updated: 1/8/2016
Click here to add this to my saved trials
Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter
Updated: 1/9/2016
Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter
Status: Enrolling
Updated: 1/9/2016
Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter
Updated: 1/9/2016
Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter
Status: Enrolling
Updated: 1/9/2016
Click here to add this to my saved trials
Alcohol and Atherosclerosis Pilot Study
Updated: 1/11/2016
Alcohol and Atherosclerosis Pilot Study
Status: Enrolling
Updated: 1/11/2016
Alcohol and Atherosclerosis Pilot Study
Updated: 1/11/2016
Alcohol and Atherosclerosis Pilot Study
Status: Enrolling
Updated: 1/11/2016
Click here to add this to my saved trials
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Status: Enrolling
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Status: Enrolling
Updated: 1/11/2016
Click here to add this to my saved trials
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Status: Enrolling
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Status: Enrolling
Updated: 1/11/2016
Click here to add this to my saved trials
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Status: Enrolling
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Status: Enrolling
Updated: 1/11/2016
Click here to add this to my saved trials
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Status: Enrolling
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Updated: 1/11/2016
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
Status: Enrolling
Updated: 1/11/2016
Click here to add this to my saved trials